Episode 133: A New Long-Acting Strategy to Fight HIV
NECA in the Know
English - March 07, 2024 06:00 - 13 minutes - 9.6 MB - ★★★★★ - 4 ratingsMedicine Health & Fitness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Episode 132: What is OI Prophylaxis?
Next Episode: Episode 134: Tackling the Bicillin LA Shortage
This week, Marianna sits down with John Faragon to talk about a new long-acting strategy to fight HIV infection. Find out how broadly neutralizing antibodies can work with lenacapavir to provide effective HIV treatment.
--
Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=CSN6278)
--
Want to chat? Email us at [email protected] with comments or ideas for new episodes.
Check out our free online courses: www.necaaetc.org/rise-courses
Download our HIV mobile apps:
Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US
Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691